A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
Clinical trial NCT04599855 · COMPLETED
Trial details
- NCT number
- NCT04599855
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2024-01-31
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.